دورية أكاديمية
Development of synthetic antigen vaccines for COVID-19.
| العنوان: | Development of synthetic antigen vaccines for COVID-19. |
|---|---|
| المؤلفون: | Viana Invenção MDC; Laboratory of Molecular Studies and Experimental Therapy - LEMTE, Department of Genetics, Federal University of Pernambuco, Recife, Pernambuco, Brazil., Melo ARDS; Laboratory of Molecular Studies and Experimental Therapy - LEMTE, Department of Genetics, Federal University of Pernambuco, Recife, Pernambuco, Brazil., de Macêdo LS; Laboratory of Molecular Studies and Experimental Therapy - LEMTE, Department of Genetics, Federal University of Pernambuco, Recife, Pernambuco, Brazil., da Costa Neves TSP; Laboratory of Molecular Studies and Experimental Therapy - LEMTE, Department of Genetics, Federal University of Pernambuco, Recife, Pernambuco, Brazil., de Melo CML; Laboratory of Immunological and Antitumor Analysis, Department of Antibiotics, Bioscience Center, Federal University of Pernambuco, Recife, Pernambuco, Brazil., Cordeiro MN; Laboratory of Molecular Studies and Experimental Therapy - LEMTE, Department of Genetics, Federal University of Pernambuco, Recife, Pernambuco, Brazil., de Aragão Batista MV; Laboratory of Molecular Genetics and Biotechnology, Department of Biology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil., de Freitas AC; Laboratory of Molecular Studies and Experimental Therapy - LEMTE, Department of Genetics, Federal University of Pernambuco, Recife, Pernambuco, Brazil. |
| المصدر: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Nov 02; Vol. 17 (11), pp. 3855-3870. Date of Electronic Publication: 2021 Oct 06. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2015- : Philadelphia, PA : Taylor & Francis Original Publication: Austin, Tex. : Landes Bioscience |
| مواضيع طبية MeSH: | COVID-19*, COVID-19 Vaccines ; Humans ; Pandemics ; SARS-CoV-2 ; Vaccines, Synthetic/genetics |
| مستخلص: | The current pandemic called COVID-19 caused by the SARS-CoV-2 virus brought the need for the search for fast alternatives to both control and fight the SARS-CoV-2 infection. Therefore, a race for a vaccine against COVID-19 took place, and some vaccines have been approved for emergency use in several countries in a record time. Ongoing prophylactic research has sought faster, safer, and precise alternatives by redirecting knowledge of other vaccines, and/or the development of new strategies using available tools, mainly in the areas of genomics and bioinformatics. The current review highlights the development of synthetic antigen vaccines, focusing on the usage of bioinformatics tools for the selection and construction of antigens on the different vaccine constructions under development, as well as strategies to optimize vaccines for COVID-19. |
| References: | Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):E4133-42. (PMID: 27382155) Cell Mol Life Sci. 2005 May;62(9):1025-37. (PMID: 15868101) Hum Vaccin Immunother. 2017 Dec 2;13(12):2837-2848. (PMID: 28604157) J Virol. 2007 Mar;81(5):2249-62. (PMID: 17182690) J Biomol Struct Dyn. 2021 May;39(8):2857-2872. (PMID: 32295479) PLoS One. 2017 Sep 1;12(9):e0184207. (PMID: 28863168) Proteins. 2017 Mar;85(3):435-444. (PMID: 27936493) J Virol. 2015 Dec;89(23):11820-33. (PMID: 26378163) JAMA. 2020 Sep 8;324(10):951-960. (PMID: 32789505) Curr Trop Med Rep. 2020;7(2):61-64. (PMID: 32219057) Mol Ther. 2019 Apr 10;27(4):757-772. (PMID: 30803823) Sci Rep. 2021 Jun 7;11(1):11998. (PMID: 34099808) J Immunol. 2003 Aug 15;171(4):1741-9. (PMID: 12902473) J Biomol Struct Dyn. 2022;40(19):9096-9113. (PMID: 34038700) Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):65-73. (PMID: 31776599) Comput Biol Med. 2021 Jun;133:104420. (PMID: 33930764) J Immunol. 2000 Jul 1;165(1):20-3. (PMID: 10861030) Nat Rev Genet. 2008 Oct;9(10):776-88. (PMID: 18781156) PLoS Comput Biol. 2008 Apr 04;4(4):e1000048. (PMID: 18389056) Lancet. 2021 Jan 9;397(10269):99-111. (PMID: 33306989) J Theor Biol. 2014 May 21;349:121-34. (PMID: 24512916) Lancet. 2020 Aug 15;396(10249):467-478. (PMID: 32702298) Trials. 2020 Oct 15;21(1):853. (PMID: 33059771) Hum Vaccin Immunother. 2020 Mar 3;16(3):723-735. (PMID: 31545127) Immunogenetics. 2005 Apr;57(1-2):33-41. (PMID: 15744535) J Infect Dis. 2013 Sep 1;208(5):818-29. (PMID: 23840043) Nature. 2020 Oct;586(7830):594-599. (PMID: 32998157) Expert Rev Vaccines. 2012 Feb;11(2):189-209. (PMID: 22309668) Intervirology. 2006;49(4):249-52. (PMID: 16601357) Gene Rep. 2020 Jun;19:100682. (PMID: 32300673) EClinicalMedicine. 2021 Jan;31:100689. (PMID: 33392485) Cell. 2020 Jun 25;181(7):1489-1501.e15. (PMID: 32473127) MMWR Morb Mortal Wkly Rep. 2021 May 14;70(19):717-718. (PMID: 33988184) Immunology. 2018 Nov;155(3):331-345. (PMID: 30014462) BMC Bioinformatics. 2005 May 31;6:132. (PMID: 15927070) Proteins. 2006 Oct 1;65(1):40-8. (PMID: 16894596) N Engl J Med. 2020 Nov 12;383(20):1920-1931. (PMID: 32663912) Bioinformatics. 2001 Dec;17(12):1236-7. (PMID: 11751237) Vaccine. 2008 Apr 16;26(17):2100-10. (PMID: 18378365) Methods Mol Biol. 2007;409:185-200. (PMID: 18450001) AIDS. 2009 Sep 24;23(15):1945-54. (PMID: 19644347) Methods Mol Biol. 2014;1184:333-64. (PMID: 25048134) BMC Bioinformatics. 2007 Oct 31;8:424. (PMID: 17973982) Viruses. 2020 Feb 25;12(3):. (PMID: 32106567) J Infect. 2021 May;82(5):e23-e24. (PMID: 33548358) Front Immunol. 2019 Feb 15;10:207. (PMID: 30828331) BMC Bioinformatics. 2007 Sep 26;8:361. (PMID: 17897458) Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):. (PMID: 34021074) Expert Rev Vaccines. 2020 Aug;19(8):699-726. (PMID: 32648830) J Immunol. 2016 Aug 15;197(4):1517-24. (PMID: 27402703) Hum Vaccin Immunother. 2012 Nov 1;8(11):1620-9. (PMID: 22894956) Nat Med. 2021 Feb;27(2):279-288. (PMID: 33335322) Nat Immunol. 2001 Mar;2(3):229-34. (PMID: 11224522) HLA. 2020 Sep;96(3):277-298. (PMID: 32475052) BMC Bioinformatics. 2007 Jan 05;8:4. (PMID: 17207271) Nature. 2020 Oct;586(7830):589-593. (PMID: 32785213) J Clin Pathol. 2021 Aug;74(8):528-532. (PMID: 32759312) Nucleic Acids Res. 2015 Jul 1;43(W1):W419-24. (PMID: 25943545) Lancet. 2020 Aug 15;396(10249):479-488. (PMID: 32702299) J Clin Exp Hepatol. 2020 Nov-Dec;10(6):610-621. (PMID: 32837093) Lancet. 2021 Feb 20;397(10275):671-681. (PMID: 33545094) Sci China Life Sci. 2020 Sep;63(9):1413-1416. (PMID: 32291557) Lancet. 2020 Sep 26;396(10255):887-897. (PMID: 32896291) Protein Eng. 2002 Apr;15(4):287-96. (PMID: 11983929) Cell. 2020 Aug 6;182(3):685-712.e19. (PMID: 32645325) Hum Gene Ther. 1999 Nov 20;10(17):2727-40. (PMID: 10584920) Nucleic Acids Res. 2017 Jul 3;45(W1):W24-W29. (PMID: 28472356) Bioinformatics. 2003 May 22;19(8):1009-14. (PMID: 12761064) mSystems. 2020 May 5;5(3):. (PMID: 32371472) Arch Med Res. 2021 Jan;52(1):15-24. (PMID: 32950264) N Engl J Med. 2021 Feb 4;384(5):403-416. (PMID: 33378609) Nat Nanotechnol. 2020 Aug;15(8):630-645. (PMID: 32661375) Bioinformatics. 2003 Sep 22;19(14):1765-72. (PMID: 14512347) Int Immunopharmacol. 2014 Mar;19(1):74-80. (PMID: 24440303) Nat Rev Immunol. 2021 Jun;21(6):340-341. (PMID: 33927376) PLoS One. 2020 Dec 22;15(12):e0244176. (PMID: 33351863) Gene Ther. 2011 Jul;18(7):702-8. (PMID: 21368901) Lancet. 2020 Jun 13;395(10240):1845-1854. (PMID: 32450106) Biotechnol Lett. 2009 Nov;31(11):1685-93. (PMID: 19579009) Nat Rev Microbiol. 2013 Dec;11(12):836-48. (PMID: 24217413) N Engl J Med. 2020 Dec 10;383(24):2320-2332. (PMID: 32877576) Cell. 2020 Aug 6;182(3):713-721.e9. (PMID: 32778225) J Virol. 2005 Aug;79(15):10083-7. (PMID: 16014971) BMC Bioinformatics. 2006 Mar 17;7:153. (PMID: 16545123) PeerJ. 2020 Jul 27;8:e9572. (PMID: 33194329) Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W526-31. (PMID: 15980527) Viruses. 2019 Jan 14;11(1):. (PMID: 30646565) Cell Host Microbe. 2020 Sep 9;28(3):364-370. (PMID: 32798444) J Immunol. 2017 Nov 1;199(9):3360-3368. (PMID: 28978689) Nucleic Acids Res. 2020 Jan 8;48(D1):D783-D788. (PMID: 31722398) J Med Virol. 2020 Jun;92(6):618-631. (PMID: 32108359) Science. 2000 Oct 20;290(5491):486-92. (PMID: 11039923) Biotechniques. 2000 Jun;28(6):1102, 1104. (PMID: 10868275) Front Immunol. 2020 Jul 28;11:1784. (PMID: 32849643) NAR Genom Bioinform. 2020 Jul 01;2(3):lqaa048. (PMID: 33575600) PLoS One. 2015 Mar 18;10(3):e0116412. (PMID: 25786238) Bioinformatics. 2014 Jun 15;30(12):1771-3. (PMID: 24532726) J Exp Med. 2009 Jul 6;206(7):1589-602. (PMID: 19564349) J Med Virol. 2020 May;92(5):495-500. (PMID: 32022276) FASEB J. 2019 Aug;33(8):8865-8877. (PMID: 31034780) Scand J Immunol. 2004 Sep;60(3):219-25. (PMID: 15320877) Biomed Res Int. 2020 May 11;2020:2683286. (PMID: 32461973) Nat Biotechnol. 2020 Oct;38(10):1132-1145. (PMID: 32989315) Virus Res. 2020 Sep;286:198074. (PMID: 32589897) Cell Mol Immunol. 2020 Aug;17(8):881-883. (PMID: 32555321) Front Immunol. 2019 Mar 27;10:594. (PMID: 30972078) Mol Immunol. 1994 Dec;31(18):1391-401. (PMID: 7823965) Eur J Immunol. 2005 Aug;35(8):2295-303. (PMID: 15997466) Cell Immunol. 2007 Nov-Dec;250(1-2):24-30. (PMID: 18275944) J Immunother. 2008 Oct;31(8):781-91. (PMID: 18779741) Microb Genom. 2023 Feb;9(2):. (PMID: 36745545) PLoS Comput Biol. 2013 Oct;9(10):e1003266. (PMID: 24204222) J Immunol. 2002 Jun 1;168(11):5499-506. (PMID: 12023344) PLoS One. 2019 Sep 18;14(9):e0222178. (PMID: 31532789) Nat Protoc. 2010 May;5(5):883-97. (PMID: 20431534) N Engl J Med. 2020 Dec 31;383(27):2603-2615. (PMID: 33301246) Immunogenetics. 2010 Jun;62(6):357-68. (PMID: 20379710) N Engl J Med. 2020 Dec 17;383(25):2439-2450. (PMID: 33053279) PLoS One. 2010 Apr 16;5(4):e9862. (PMID: 20419125) Science. 2020 Sep 4;369(6508):1249-1255. (PMID: 32680882) Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W363-7. (PMID: 15980490) Nat Biotechnol. 2019 Oct;37(10):1174-1185. (PMID: 31570898) Mol Immunol. 2010 Apr;47(7-8):1507-15. (PMID: 20189249) Immunology. 2014 Jan;141(1):18-26. (PMID: 23927693) |
| فهرسة مساهمة: | Keywords: SARS-CoV-2; adjuvants; immunoinformatics; in silico; nucleic acid vaccines |
| المشرفين على المادة: | 0 (COVID-19 Vaccines) 0 (Vaccines, Synthetic) |
| تواريخ الأحداث: | Date Created: 20211006 Date Completed: 20220114 Latest Revision: 20231105 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC8506811 |
| DOI: | 10.1080/21645515.2021.1974288 |
| PMID: | 34613880 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 2164-554X |
|---|---|
| DOI: | 10.1080/21645515.2021.1974288 |